ITCI

Intra Cellular Therapies Stock Price

35.03
1.60 (4.79%)
Upgrade to Real-Time
Afterhours (Closed)
35.03

Low
16.90

52 Week Range

High
42.99

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Intra Cellular Therapies Inc ITCI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.60 4.79% 35.03 18:00:32
Open Price Low Price High Price Close Price Prev Close
33.85 33.4439 35.07 35.03 33.43
Bid Price Ask Price Spread News
27.86 36.37 8.51 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,344 526,396 $ 34.49 $ 18,157,209 496,153 16.90 - 42.99
Last Trade Time Type Quantity Stock Price Currency
19:56:05 5 $ 35.03 USD

Intra Cellular Therapies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.84B 81.20M 60.70M $ 22.53M $ - -3.23 -10.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 4.00k 2.60%

more financials information »

Intra Cellular Therapies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ITCI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week34.3435.0731.4032.89616,2500.692.01%
1 Month31.4035.0728.8031.93503,1093.6311.56%
3 Months38.9440.00528.8034.39548,816-3.91-10.04%
6 Months24.8540.00523.3831.55654,34710.1840.97%
1 Year18.5542.9916.9028.131,013,82316.4888.84%
3 Years18.0443.566.7522.89914,99416.9994.18%
5 Years31.1745.206.7521.46799,0633.8612.38%

Intra Cellular Therapies Description

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.


Your Recent History
NASDAQ
ITCI
Intra Cell..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.